Published in Gene Therapy Weekly, December 28th, 2000
Researchers at the University of North Carolina, Chapel Hill, and at Niigata University, Japan, conducted their gene targeting experiment in hematopoietic progenitor cells in culture, noting that these cells are "more abundant and more mature and so less pluripotent" than hematopoietic stem cells (HSCs). They reported their findings in the the Proceedings of the National Academy of Sciences ("Gene correction in hematopoietic progenitor cells by homologous recombination," PNAS, December 5,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.